Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76826 - 76850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Tamoxifen	Approved Investigational	ITPR1	3708	upregulated	Tamoxifen results in increased expression of ITPR1 mRNA	3p26.1	A21152
Tamoxifen	Approved Investigational	IVL	3713	downregulated	Tamoxifen results in decreased expression of IVL mRNA	1q21.3	A24383
Tamoxifen	Approved Investigational	KCNA5	3741	downregulated	Tamoxifen results in decreased expression of KCNA5 mRNA	12p13.32	A24383
Tamoxifen	Approved Investigational	KCNJ1	3758	upregulated	Tamoxifen results in increased expression of KCNJ1 mRNA	11q24.3	A24384
Tamoxifen	Approved Investigational	KDM5A	5927	upregulated	Tamoxifen results in increased expression of KDM5A mRNA	12p13.33	A24383
Tamoxifen	Approved Investigational	KIF23	9493	upregulated	Tamoxifen results in increased expression of KIF23 mRNA	15q23	A24383
Tamoxifen	Approved Investigational	KLRC1	3821	upregulated	Tamoxifen results in increased expression of KLRC1 mRNA	12p13	A21164
Tamoxifen	Approved Investigational	KLRC3	3823	upregulated	Tamoxifen results in increased expression of KLRC3 mRNA	12p13.2	A21320
Tamoxifen	Approved Investigational	KRT86	3892	downregulated	Tamoxifen results in decreased expression of KRT86 mRNA	12q13	A24383
Tamoxifen	Approved Investigational	KYNU	8942	upregulated	Tamoxifen results in increased expression of KYNU mRNA	2q22.2	A3616
Tamoxifen	Approved Investigational	L3MBTL1	26013	downregulated	Tamoxifen results in decreased expression of L3MBTL1 mRNA	20q13.12	A21112
Tamoxifen	Approved Investigational	LARP6	55323	upregulated	Tamoxifen results in increased expression of LARP6 mRNA	15q23	A3616
Tamoxifen	Approved Investigational	LEF1	51176	upregulated	Tamoxifen results in increased expression of LEF1 mRNA	4q25	A24383
Tamoxifen	Approved Investigational	LGALS3BP	3959	upregulated	Tamoxifen results in increased expression of LGALS3BP mRNA	17q25	A24384
Tamoxifen	Approved Investigational	LSS	4047	downregulated	Tamoxifen results in decreased expression of LSS mRNA	21q22.3	A24383
Tamoxifen	Approved Investigational	LSS	4047	upregulated	Tamoxifen results in increased expression of LSS mRNA	21q22.3	A20438 A20646
Tamoxifen	Approved Investigational	MAP1A	4130	upregulated	Tamoxifen results in increased expression of MAP1A mRNA	15q15.3	A24383
Tamoxifen	Approved Investigational	MAP2K4	6416	upregulated	Tamoxifen results in increased expression of MAP2K4 mRNA	17p12	A24383
Tamoxifen	Approved Investigational	MAP3K20	51776	downregulated	Tamoxifen results in decreased expression of MAP3K20 mRNA	2q31.1	A21112
Tamoxifen	Approved Investigational	MAPK11	5600	downregulated	Tamoxifen results in decreased expression of MAPK11 mRNA	22q13.33	A24383
Tamoxifen	Approved Investigational	MAT1A	4143	downregulated	Tamoxifen results in decreased expression of MAT1A mRNA	10q22.3	A24383
Tamoxifen	Approved Investigational	MC2R	4158	downregulated	Tamoxifen results in decreased expression of MC2R mRNA	18p11.2	A24383
Tamoxifen	Approved Investigational	MCM7	4176	downregulated	Tamoxifen results in decreased expression of MCM7 mRNA	7q22.1	A3616
Tamoxifen	Approved Investigational	MLANA	2315	downregulated	Tamoxifen results in decreased expression of MLANA mRNA	9p24.1	A24383
Tamoxifen	Approved Investigational	MR1	3140	upregulated	Tamoxifen results in increased expression of MR1 mRNA	1q25.3	A21112

Displaying entries 76826 - 76850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability